NO20004583D0 - Krystallinsk form av paroxetine - Google Patents

Krystallinsk form av paroxetine

Info

Publication number: NO20004583D0
Authority: NO; Norway
Prior art keywords: paroxetine; crystalline form; crystalline
Prior art date: 1998-03-16

Application number

NO20004583A

Other languages

English (en)

Other versions

NO20004583L (no

Inventor

Andrew Simon Craig

Neal Ward

Wilson Mcilwaine

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-16

Filing date

2000-09-14

Publication date

2000-09-14

1998-03-16 Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en

1998-06-17 Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en

1998-08-06 Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en

2000-09-14 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-09-14 Publication of NO20004583D0 publication Critical patent/NO20004583D0/no

2000-09-15 Publication of NO20004583L publication Critical patent/NO20004583L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20004583A 1998-03-16 2000-09-14 Krystallinsk form av paroxetine NO20004583L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9805581.7A GB9805581D0 (en)	1998-03-16	1998-03-16	Novel compounds
GBGB9813054.5A GB9813054D0 (en)	1998-06-17	1998-06-17	Novel compounds
GBGB9817115.0A GB9817115D0 (en)	1998-08-06	1998-08-06	Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en)	1998-03-16	1999-03-16	Crystalline form of paroxetine

Publications (2)

Publication Number	Publication Date
NO20004583D0 true NO20004583D0 (no)	2000-09-14
NO20004583L NO20004583L (no)	2000-09-15

Family

ID=27269245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004583A NO20004583L (no)	1998-03-16	2000-09-14	Krystallinsk form av paroxetine

Country Status (18)

Country	Link
EP (1)	EP1064282A1 (no)
JP (1)	JP2002506865A (no)
KR (1)	KR20010041947A (no)
CN (1)	CN1300286A (no)
AP (1)	AP2000001907A0 (no)
AU (1)	AU2847199A (no)
BG (1)	BG104839A (no)
BR (1)	BR9908825A (no)
CA (1)	CA2323896A1 (no)
EA (1)	EA200000946A1 (no)
HU (1)	HUP0101215A3 (no)
ID (1)	ID27596A (no)
IL (1)	IL138390A0 (no)
NO (1)	NO20004583L (no)
PL (1)	PL342931A1 (no)
SK (1)	SK13622000A3 (no)
TR (1)	TR200002675T2 (no)
WO (1)	WO1999047519A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) *	1999-08-12	1999-10-13	Smithkline Beecham Plc	Novel compound composition and process
US20080033050A1 (en) *	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
ES2058061T3 (es) *	1985-10-25	1994-11-01	Beecham Group Plc	Derivado de piperidina, su preparacion y su uso como medicamento.
SK283608B6 (sk) *	1995-02-06	2003-10-07	Smithkline Beecham Plc	Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie

1999
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Withdrawn
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Ceased
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown

Also Published As

Publication number	Publication date
CN1300286A (zh)	2001-06-20
JP2002506865A (ja)	2002-03-05
TR200002675T2 (tr)	2000-12-21
NO20004583L (no)	2000-09-15
BR9908825A (pt)	2000-11-21
ID27596A (id)	2001-04-12
HUP0101215A3 (en)	2002-05-28
BG104839A (en)	2001-09-28
IL138390A0 (en)	2001-10-31
SK13622000A3 (sk)	2001-03-12
AU2847199A (en)	1999-10-11
WO1999047519A1 (en)	1999-09-23
HUP0101215A2 (hu)	2002-04-29
KR20010041947A (ko)	2001-05-25
EA200000946A1 (ru)	2001-02-26
PL342931A1 (en)	2001-07-16
AP2000001907A0 (en)	2000-09-30
CA2323896A1 (en)	1999-09-23
EP1064282A1 (en)	2001-01-03

Publication	Publication Date	Title
ID29021A (id)	2001-07-26	Komposisi galantamina pelepasan terkontrol
NO20011083L (no)	2001-05-03	Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH
ID27092A (id)	2001-03-01	Pembuatan ftalat anhidrida
DE60038481D1 (de)	2008-05-15	Kristalline form des (r)-2-äää3-methyl-4-(2,2,2-trifluorethoxy)-2-pyridinylümethylüsulfinylü-1h-benzimidazols
PT945132E (pt)	2004-08-31	Composicao de ibuprofeno
BR9711151A (pt)	1999-08-17	Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida
PT1089996E (pt)	2004-02-27	Metanossulfonato de paroxetina
IS2019B (is)	2005-06-15	Nýtt kristallað form kalíumsalts (S)-ómeprasóls
NO20010899D0 (no)	2001-02-22	Forbedring av ugunstige apomorfin-effekter
NO20020030D0 (no)	2002-01-04	Krystallinske 1-metylcarbapenemforbindelser
NO993460D0 (no)	1999-07-14	Paroxetine-preparater
NO20016151D0 (no)	2001-12-17	Fremstilling av substituerte piperidin-4-oner
ATE282038T1 (de)	2004-11-15	Kristallin form ii von cabergolin
NO20006547D0 (no)	2000-12-21	Salter av paroxetine
NO20010553L (no)	2001-04-05	Krystallinske former av osanetant
NO20003960D0 (no)	2000-08-04	Salter av paroksetin
ID28032A (id)	2001-05-03	TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO20013857L (no)	2001-10-08	Krystallinsk form av Eplerenon
FI980222A0 (fi)	1998-01-30	Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
PT1178984E (pt)	2003-06-30	Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20004583D0 (no)	2000-09-14	Krystallinsk form av paroxetine
EE200100017A (et)	2002-06-17	N-tert-butüülhüdroksüülamiini uued soolad
EE200100381A (et)	2002-12-16	Morfolinobensamiidi uued soolad
PT1175417E (pt)	2004-04-30	Compostos substituidos de benzolactamas
DE59907344D1 (de)	2003-11-20	Feinteiliges kristallines Natriumdisilikat

Legal Events

Date	Code	Title	Description
2002-11-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application